POMDOCTOR LIMITED

Pomdoctor Regains Nasdaq Bid Price Compliance, Hearing Cancelled

GUANGZHOU – November 07, 2026 -- POMDOCTOR LIMITED (NASDAQ: POM) has regained compliance with Nasdaq's $1.00 minimum bid price requirement, removing the immediate threat of delisting for its Class A ordinary shares.

The company received a compliance letter from The Nasdaq Stock Market LLC on November 5, 2026, confirming it meets Listing Rule 5450(a)(1). The Nasdaq Hearings Panel hearing originally scheduled for November 12, 2026 has been cancelled as a result.

Nasdaq issued a staff delisting determination on October 6 after 30 straight business days below $1.00

The compliance confirmation follows a staff delisting determination letter dated October 6, 2026. Nasdaq had found that the closing bid price of Pomdoctor's securities was below $1.00 per share for 30 consecutive business days.

Pomdoctor Targets Predictive Healthcare With AI and Wearables

Guangzhou – October 13, 2026 -- Nasdaq-listed Pomdoctor Limited (POM) said it will integrate AI, wearable devices, remote patient monitoring (RPM) and real-world healthcare data with its existing physician resources, aiming to move care from "diagnose and treat" to "predict, alert and intervene."

Pomdoctor bets on chronic disease management as the first use case

The company said continuous monitoring and timely intervention are particularly relevant to chronic disease management. Wearables and RPM can collect health indicators outside clinical settings, while longitudinal and real-world data give a broader view of changes in an individual's health status. AI would analyze these datasets, flag potential risk signals and support earlier healthcare decisions.

Pomdoctor Bets on Hardware-AI-Payment Model for Digital Health

Guangzhou – September 25, 2026 -- Pomdoctor Limited (NASDAQ: POM) outlined a differentiated "hardware plus AI plus payment" infrastructure model that it says sets the company apart from traditional internet healthcare platforms, which typically operate in silos around discrete services such as online consultations or pharmaceutical transactions.

Pomdoctor targets full-cycle predictive healthcare integration

The Guangzhou-based digital healthcare company said its system is designed to combine continuous health monitoring, AI-powered analysis, physician intervention, healthcare payment and fulfillment into a single closed-loop ecosystem, rather than offering standalone services.